Top

World Journal of Surgical Oncology

Published in:

Open Access 01-12-2014 | Research

Over-expression of a poor prognostic marker in prostate cancer: AQP5 promotes cells growth and local invasion

Authors: Jianping Li, Ziming Wang, Tie Chong, Haiwen Chen, Hechen Li, Gang Li, Xiaoqiang Zhai, Youfang Li

Published in: World Journal of Surgical Oncology | Issue 1/2014

Abstract

Background

The aquaporins (AQPs), water channel proteins, are known playing a major role in transcellular and transepithelial water movement; they also exhibit several properties related to tumor development. The aim of the present study is to elucidate whether the expression of AQP5 is a strong prognostic biomarker for prostate cancer, and the potential role in the progression of prostate cancer cells.

Methods

AQP5 expression was measured in 60 prostate cancer tissues and cells (both PC-3 and LNCaP) by immunohistochemistry and immunofluorescence assay. AQP5 gene amplification was detected with FISH (fluorescence in situ hybridization). Proliferation and migration of cells and AQP5 siRNA cells were detected with MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) and Boyden chambers. Circulating tumor cells (CTCs) were detected by imFISH staining (CEP8-CD45-DAPI) assay.

Results

The results showed that in 60 tumor specimens, 19 (31.7%) patients showed high level of AQP5 expression, while 30 (50.0%) showed a moderate, intermediate level of staining, and 11 (18.3%) showed an absence of AQP5 staining, respectively. High-expression of AQP5 protein frequently accompanied gene amplification detection with FISH. The AQP5 over-expression was also associated with TNM stage (P = 0.042), and lymph node metastasis (P = 0.001). The relationships between age or tumor size with the expression of AQP5 were not significant (P > 0.05). A positive correlation between the number of CTCs and AQP5 expression (P < 0.05) was demonstrated. In addition, patients who were negative for AQP5 had superior cumulative survival rate than those who were positive for it. Over-expression of AQP5 protein was also found in prostate cancer cells and cell proliferation and migration were significantly attenuated by AQP5-siRNA.

Conclusions

We concluded that AQP5 in prostate cancer was an independent prognostic indicator. AQP5 over-expression was likely to play a role in cell growth and metastasis. These conclusions suggest that AQP5 may be an effective therapeutic target for prostate cancer.

Available only for authorised users

Snyder A, Tepper JE, Slovin SF: Perspectives on immunotherapy in prostate cancer and solid tumors: where is the future?. Semin Oncol. 2013, 40: 347-360. 10.1053/j.seminoncol.2013.04.009.CrossRefPubMed

Bhavsar T, McCue P, Birbe R: Molecular diagnosis of prostate cancer: are we up to age?. Semin Oncol. 2013, 40: 259-275. 10.1053/j.seminoncol.2013.04.002.CrossRefPubMed

Sekine S, Shimada Y, Nagata T, Moriyama M, Omura T, Watanabe T, Hori R, Yoshioka I, Okumura T, Sawada S, Fukuoka J, Tsukada K: Prognostic significance of aquaporins in human biliary tract carcinoma. Oncol Rep. 2012, 27: 1741-1747.PubMed

Burghardt B, Elkaer ML, Kwon TH, Racz GZ, Varga G, Steward MC, Nielsen S: Distribution of aquaporin water channels AQP1 and AQP5 in the ductal system of the human pancreas. Gut. 2003, 52: 1008-1016. 10.1136/gut.52.7.1008.PubMedCentralCrossRefPubMed

Delporte C, Steinfeld S: Distribution and roles of aquaporins in salivary glands. Biochim Biophys Acta. 2006, 1758: 1061-1070. 10.1016/j.bbamem.2006.01.022.CrossRefPubMed

McCoy E, Sontheimer H: Expression and function of water channels (aquaporins) in migrating malignant astrocytes. Glia. 2007, 55: 1034-1043. 10.1002/glia.20524.PubMedCentralCrossRefPubMed

Ismail M, Bokaee S, Morgan R, Davies J, Harrington KJ, Pandha H: Inhibition of the aquaporin 3 water channel increases the sensitivity of prostate cancer cells to cryotherapy. Br J Cancer. 2009, 100: 1889-1895. 10.1038/sj.bjc.6605093.PubMedCentralCrossRefPubMed

Wang J, Tanji N, Kikugawa T, Shudou M, Song X, Yokoyama M: Expression of aquaporin 3 in the human prostate. Int J Urol. 2007, 14: 1088-1092. 10.1111/j.1442-2042.2007.01901.x. 1092CrossRefPubMed

Mobasheri A, Airley R, Hewitt SM, Marples D: Heterogeneous expression of the aquaporin 1 (AQP1) water channel in tumors of the prostate, breast, ovary, colon and lung: a study using high density multiple human tumor tissue microarrays. Int J Oncol. 2005, 26: 1149-1158.PubMed

10.

Woo J, Lee J, Chae YK, Kim MS, Baek JH, Park JC, Park MJ, Smith IM, Trink B, Ratovitski E, Lee T, Park B, Jang SJ, Soria JC, Califano JA, Sidransky D, Moon C: Overexpression of AQP5, a putative oncogene, promotes cell growth and transformation. Cancer Lett. 2008, 264: 54-62. 10.1016/j.canlet.2008.01.029.PubMedCentralCrossRefPubMed

11.

Kang SK, Chae YK, Woo J, Kim MS, Park JC, Lee J, Soria JC, Jang SJ, Sidransky D, Moon C: Role of human aquaporin 5 in colorectal carcinogenesis. Am J Pathol. 2008, 173: 518-525. 10.2353/ajpath.2008.071198.PubMedCentralCrossRefPubMed

12.

Clyne M: Prostate cancer: androgen deprivation causes EMT in the prostate. Nat Rev Urol. 2012, 9: 4-CrossRef

13.

Lee SJ, Chae YS, Kim JG, Kim WW, Jung JH, Park HY, Jeong JY, Park JY, Jung HJ, Kwon TH: AQP5 Expression Predicts Survival in Patients with Early Breast Cancer. Ann Surg Oncol. 2013, 21 (2): 375-383.CrossRefPubMed

14.

Shen L, Zhu Z, Huang Y, Shu Y, Sun M, Xu H, Zhang G, Guo R, Wei W, Wu W: Expression profile of multiple aquaporins in human gastric carcinoma and its clinical significance. Biomed Pharmacother. 2010, 64: 313-318. 10.1016/j.biopha.2009.12.003.CrossRefPubMed

15.

Yang JH, Yu YQ, Yan CX: Localisation and expression of aquaporin subtypes in epithelial ovarian tumours. Histol Histopathol. 2011, 26: 1197-1205.PubMed

16.

Wang W, Li Q, Yang T, Bai G, Li D, Li Q, Sun H: Expression of AQP5 and AQP8 in human colorectal carcinoma and their clinical significance. World J Surg Oncol. 2012, 10: 242-10.1186/1477-7819-10-242.PubMedCentralCrossRefPubMed

17.

Zhang ZQ, Zhu ZX, Bai CX: Lung fluorescence imaging to evaluate tumor metastasis induced by AQP5 expression in murine model. Med Oncol. 2012, 29: 205-211. 10.1007/s12032-010-9788-5.CrossRefPubMed

18.

Chae YK, Kang SK, Kim MS, Woo J, Lee J, Chang S, Kim DW, Kim M, Park S, Kim I, Keam B, Rhee J, Koo NH, Park G, Kim SH, Jang SE, Kweon IY, Sidransky D, Moon C: Human AQP5 plays a role in the progression of chronic myelogenous leukemia (CML). PLoS One. 2008, 3: e2594-10.1371/journal.pone.0002594.PubMedCentralCrossRefPubMed

19.

Woo J, Lee J, Kim MS, Jang SJ, Sidransky D, Moon C: The effect of aquaporin 5 overexpression on the Ras signaling pathway. Biochem Biophys Res Commun. 2008, 367: 291-298. 10.1016/j.bbrc.2007.12.073.CrossRefPubMed

20.

Huang YH, Zhou XY, Wang HM, Xu H, Chen J, Lv NH: Aquaporin 5 promotes the proliferation and migration of human gastric carcinoma cells. Tumour Biol. 2013, 34: 1743-1751. 10.1007/s13277-013-0712-4.CrossRefPubMed

21.

Fischer H, Stenling R, Rubio C, Lindblom A: Differential expression of aquaporin 8 in human colonic epithelial cells and colorectal tumors. BMC Physiol. 2001, 1: 1-10.1186/1472-6793-1-1.PubMedCentralCrossRefPubMed

22.

Chae YK, Woo J, Kim MJ, Kang SK, Kim MS, Lee J, Lee SK, Gong G, Kim YH, Soria JC, Jang SJ, Sidransky D, Moon C: Expression of aquaporin 5 (AQP5) promotes tumor invasion in human non small cell lung cancer. PLoS One. 2008, 3: e2162-10.1371/journal.pone.0002162.PubMedCentralCrossRefPubMed

23.

Burg MB, Ferraris JD, Dmitrieva NI: Cellular response to hyperosmotic stresses. Physiol Rev. 2007, 87: 1441-1474. 10.1152/physrev.00056.2006.CrossRefPubMed

24.

Saadoun S, Papadopoulos MC, Hara-Chikuma M, Verkman AS: Impairment of angiogenesis and cell migration by targeted aquaporin-1 gene disruption. Nature. 2005, 434: 786-792. 10.1038/nature03460.CrossRefPubMed

25.

Hu J, Verkman AS: Increased migration and metastatic potential of tumor cells expressing aquaporin water channels. FASEB J. 2006, 20: 1892-1894. 10.1096/fj.06-5930fje.CrossRefPubMed

26.

Verkman AS: More than just water channels: unexpected cellular roles of aquaporins. J Cell Sci. 2005, 118: 3225-3232. 10.1242/jcs.02519.CrossRefPubMed

27.

Onstenk W, Gratama JW, Foekens JA, Sleijfer S: Towards a personalized breast cancer treatment approach guided by circulating tumor cell (CTC) characteristics. Cancer Treat Rev. 2013, 39: 691-700. 10.1016/j.ctrv.2013.04.001.CrossRefPubMed

28.

Attard G, Crespo M, Lim AC, Pope L, Zivi A, De Bono JS: Reporting the capture efficiency of a filter-based microdevice: a CTC is not a CTC unless it is CD45 negative -letter. Clin Cancer Res. 2011, 17: 3048-3049. 10.1158/1078-0432.CCR-10-3234. 3050CrossRefPubMed

29.

Coumans FA, Ligthart ST, Uhr JW, Terstappen LW: Challenges in the enumeration and phenotyping of CTC. Clin Cancer Res. 2012, 18: 5711-5718. 10.1158/1078-0432.CCR-12-1585.CrossRefPubMed

30.

Lustberg M, Jatana KR, Zborowski M, Chalmers JJ: Emerging technologies for CTC detection based on depletion of normal cells. Recent Results Cancer Res. 2012, 195: 97-110. 10.1007/978-3-642-28160-0_9.PubMedCentralCrossRefPubMed

Title: Over-expression of a poor prognostic marker in prostate cancer: AQP5 promotes cells growth and local invasion
Authors: Jianping Li
Ziming Wang
Tie Chong
Haiwen Chen
Hechen Li
Gang Li
Xiaoqiang Zhai
Youfang Li
Publication date: 01-12-2014
Publisher: BioMed Central
Published in: World Journal of Surgical Oncology / Issue 1/2014
Electronic ISSN: 1477-7819
DOI: https://doi.org/10.1186/1477-7819-12-284

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Over-expression of a poor prognostic marker in prostate cancer: AQP5 promotes cells growth and local invasion

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2014

Marginal resection for osteosarcoma with effective neoadjuvant chemotherapy: long-term outcomes

Splenic hamartomas in two children

Attention dysfunction of postoperative patients with glioma

Intra-abdominal desmoid tumor mimicking gastric cancer recurrence: a case report

Metastasis of distal esophageal carcinoma to the thyroid with presentation simulating primary thyroid carcinoma: a case report and review of the literature

Decoy receptor 3 (DcR3) overexpression predicts the prognosis and pN2 in pancreatic head carcinoma